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A B S T R A C T
The eyes absent (EYA)-like genes are essential for the formation of sensory organs among ﬂy (Drosophila mela-
nogaster) and mammals. EYA4, one of the vertebrate genes of Eya family, is reported to be causative for late-onset
mid-frequency sensorineural hearing loss in humans, while Eya4-deﬁcient mice exhibited congenital profound
deafness and otitis media with eﬀusion due to the eustachian tube dysmorphology. Because of the species dif-
ference in the phenotype, the pathophysiology of EYA4 in the human cochlea has yet to be elucidated.
Here, we examine the expression pattern of EYA4 in the cochlea of common marmoset (Callithrix jacchus), a
non-human primate. The results indicated a distinct expression pattern of EYA4 in the adult marmoset cochleae,
especially strong in all supporting cells, while in mouse their expressions were diminished. Interestingly, EYA4
expression in the hair cells, supporting cells and neurons was co-localized with sine oculis homeobox–SIX1, a
transcription factor essential for the transcriptional activity of EYA4. The results revealed inter-species diﬀer-
ences in the expression pattern of EYA4 gene in supporting cells between primates and rodents. The results also
indicated a fundamental role of EYA4 in the primate auditory cells. Experiments with primate models such as
marmosets or with human cochlear cells may provide cues about the unknown pathogenesis of EYA4-related
hearing loss.
1. Introduction
The eyes absent (EYA)-like gene EYA4 is reported to cause mid-fre-
quency hearing loss. First identiﬁed in 1996 as an autosomal-dominant
non-syndromic hearing loss (ADNSHL) gene by linkage analysis of an
American family, EYA4 was mapped to chromosomes 6q22.3–q23.2
[1,2]. EYA4 encodes a 639-amino-acid protein called the EYA4 protein
[3]. Mammalian EYA proteins translocate into the nucleus in associa-
tion with members of the sine oculis homeobox (SIX) family of tran-
scription factors [4]. EYA4 contains a highly conserved Eya domain
(eya-HR) and a variable domain (eya-VR) [5]. The eya-HR and the SIX
family of transcription factors interact to form transcriptional com-
plexes that regulate the expression of target genes [4].
Mutations of EYA4 are known to cause post-lingual and progressive
syndromic or non-syndromic (DFNA10) sensorineural hearing loss,
depending on the location of the truncation of the mutant protein.
DFNA10 is the tenth genetic locus identiﬁed in ADNSHL [6]. To date,
eight EYA4 mutations associated with non-syndromic hearing loss have
been identiﬁed [1,7].
Generally, experimental animals such as mice and zebraﬁsh have
been widely used to clarify the pathophysiology of deafness [8,9].
However, Eya4-deﬁcient mice exhibited profound early-onset hearing
defects with severe otitis media with eﬀusion due to eustachian tube
dysmorphology. In humans, EYA4 mutations caused post-lingual sen-
sorineural and progressive hearing loss typically occurring between the
ages of 20 and 30 years [10]. In contrast to rodents, neither otitis media
eﬀusion nor pre-lingual congenital hearing loss was reported in pa-
tients. Therefore, the human EYA4-related hearing loss seems diﬀerent
from that in mice. Because of the phenotypic discrepancies between
rodents and humans, the pathophysiological role of EYA4 mutations in
human cochlea remains to be elucidated. We therefore investigated the
expression pattern of EYA4 in the cochlea of the common marmoset
(Callithrix jacchus), a non-human primate in which more than 50 genes
have been inspected in our previous studies [11–13]. Our results in-
dicated the expression of EYA4 in the adult cochlear sensory epithelium
and spiral ganglion neuron, which is the primary neuron in the auditory
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system. The expression pattern was quite unique and diﬀerent from that
of rodents. These diﬀerences may account for the phenotypic dis-
crepancies between Eya4-deﬁcient mice and humans with EYA4 mu-
tations. Our present ﬁndings thus suggested a fundamental role of EYA4
in the maintenance of cochlear sensory epithelium in primates, in-
cluding humans.
2. Materials and methods
2.1. Animals
Fixed and decapitated cadaverous heads of 3–6-year-old common
marmosets were kindly provided by Takeshi Inoue, Reona Kobayashi,
Takahiro Kondo, Kimika Yoshino-Saito, and Seiji Shiozawa. The animal
experiments were approved by the Animal Committee of Keio
University (number 11006) and were in accordance with the guidelines
of the National Institutes of Health and the Ministry of Education,
Culture, Sports, Science, and Technology of Japan.
2.2. Tissue preparation
All marmosets were transcardially perfused with saline, followed by
ﬁxation with 4% paraformaldehyde (Nacalai Tesque, Kyoto, Japan).
The temporal bones were dissected, decalciﬁed with ethylenediamine-
tetraacetic acid (EDTA) for 4 weeks at room temperature, and subse-
quently cryosectioned into 7-μm thick sections for
Fig. 1. EYA4 expression in the cochlea of common marmoset. (A) Cross-section of the common marmoset cochlear duct under low magniﬁcation. (B) Cross-section of the common
marmoset cochlear duct under high magniﬁcation. OC, organ of corti; SG, spiral ganglion. The nuclei were counterstained with Hoechst (blue). Scale bar: 200 μm in (A) and 100 μm in
(B). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
The inner and outer hair cells had co-expression of Myo7a (in cytoplasm) and EYA4 (nucleus). All supporting cells and spiral ganglion cells had expressions of EYA4 (nucleus).
Fig. 2. EYA4 expression in organ of Corti. (A) Middle turn. EYA4 expression was observed in the outer hair cells, inner hair cells, inner sulcus cells, Hensen’s cells, Claudius cells, inner
pillar cells and outer pillar cells. (B) Basal turn. EYA4 expression was observed in the outer hair cells, inner hair cells, inner sulcus cells, Hensen’s cells, Claudius cells, inner pillar cells and
outer pillar cells. OHC, outer hair cell; IHC, inner hair cell; OSC, outer sulcus cell; ISC, inner sulcus cell; IPC, inner pillar cell; OPC, outer pillar cell; CC, Claudius cell; HC, Hensen’s cell;
IPhC, Inner Phalangeal cell. Nuclei were counterstained with Hoechst (blue). Scale bar: 50 μm in (A and B). (For interpretation of the references to colour in this ﬁgure legend, the reader
is referred to the web version of this article.)
The inner and outer hair cells had co-expression of Myo7a (in cytoplasm), EYA4 (nucleus), and SIX1 (nucleus). All supporting cells had co-expressions of EYA4 and SIX1 (nucleus).




After a brief wash with phosphate-buﬀered saline (PBS), the sec-
tions were heated in 10 mM citrate buﬀer (pH 6) for 60 min.
Subsequently, the sections were rinsed with PBS and non-speciﬁc
binding was blocked by 60-min incubation in PBS containing 10%
normal serum at room temperature. The sections were then incubated
with primary antibodies overnight at 4 °C, followed by Alexa Fluor-
conjugated secondary antibodies (Alexa 488, Molecular Probes,
Eugene, Oregon, USA; 99E2-2, Alexa 555, and Alexa 647, Invitrogen,
Waltham, Massachusetts, USA) for 60 min at room temperature. The
nuclei were counterstained with Hoechst 33342.
2.4. Antibodies
The primary antibodies used in this study were anti-EYA4 (rabbit
IgG, HPA004805, 1:50; Atlas Antibodies, Voltavagen, Bromma,
Sweden), anti-myosin 7a (mouse IgG, 138-1-s, 1:30; Developmental
Studies Hybridoma Bank, Iowa City, Iowa, USA), and anti-SIX1(A-20)
(goat IgG, sc-9709, 1:50; Santa Cruz Biotechnology, Bergheimer Str,
Heidelberg, Germany).
3. Results
In the marmoset cochlea, EYA4 immunoreactivity was observed in
spiral ganglion neurons, inner/outer hair cells, all supporting cells in-
cluding the Deiters’, Hensen’s, and Claudius cells, inner/outer pillar
cells, and inner/outer sulcus cells (Figs. 1–3, Table 1). No im-
munoreactivity was observed in the stria vascularis, lateral wall ﬁ-
brocytes, and Reissner’s membrane. There was no diﬀerence in the
pattern of expressions among the turns of the cochlear spiral (Fig. 2).
Furthermore, our results revealed an EYA4-SIX1 co-localization in the
cells of the organ of Corti including the inner/outer hair cells and the
spiral ganglion neurons (Fig. 2).
4. Discussion
In the present study, we examined EYA4 expression in the marmoset
cochlea. EYA4 was in particular detected in spiral ganglion neurons,
inner/outer hair cells, all supporting cells, inner/outer pillar cells, and
inner/outer sulcus cells. Because there is to date no report describing
EYA4 gene expression in the human temporal bone or the temporal
bone pathology in EYA4 mutations, our study is the ﬁrst report to de-
scribe the behavior of the EYA4 gene in the cochlea of primates.
4.1. Species diﬀerences
In rodents, it has been previously reported, using in situ hybridiza-
tion, that Eya4 is expressed in the early stage of the otic vesicle, mostly
restricted to the upper cochlear duct within cells that develop into the
stria vascularis and Reissner’s membrane, and eventually to spiral
limbus, organ of Corti, and spiral prominence [14]. In contrast with
these ﬁndings in rodents, our present results revealed the expression of
EYA4 in several diﬀerent parts of the adult marmoset cochlea (Table 1).
The spatiotemporal EYA4 expression pattern in the marmoset was quite
diﬀerent from that in rodents, where Eya4 was strongly expressed in the
fetal cochlea, but decreased markedly thereafter. These discrepancies
may account for the phenotypic diﬀerences between human EYA4
mutation (progressive sensorineural hearing loss) and Eya4-deﬁcient
mice (early-onset of hearing defects and otitis media with eﬀusion).
4.2. EYA4 expression pattern in marmosets
We have previously examined the expression patterns of more than
50 genes in the marmoset cochleae and, notably reported a discrepancy
between the expression of the genes in the cochleae of marmosets and
rodents. In particular, seven genes (CX31, CRYM, GRHL2, DFNA5,
ATP6B1, KIAA1199, and WFS1), which are genes causative of deafness
in humans, but not in mice model, were expressed in the marmoset
cochlea diﬀerently than in the rodents cochlea [11–13]. Our present
results indicated that EYA4, similarly to the seven above-mentioned
gene expressions, exhibited also a diﬀerential expression pattern be-
tween the marmosets and rodents. The “primate pattern” expression at
the level of transcription factors may explain the evolutionary acqui-
sition of primate pattern genes in the cochlea.
Fig. 3. EYA4 expression in the spiral ganglion neurons. EYA4 expression was observed in the spiral ganglion. SG, spiral ganglion. Nuclei were counterstained with Hoechst (blue). Scale
bar: 100 μm. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Spiral ganglion cells had co-expressions of EYA4 and SIX1 (nucleus).
Table 1
Expression pattern of EYA4 in the common marmoset (Callithrix jacchus) cochlea and
mouse.
marmoset mouse
(3 weeks after birth)
Inner hair cell + +
Outer hair cell + +
Stria vascularis: Marginal – –
Stria vascularis: Intermediate – –
Stria vascularis: Basal – –
Spiral ganglion + ±
Lateral wall ﬁbrocytes – –
Outer sulcus cells + –
Claudius cells + –
Hensen's cells + –
Deiters’ cells + ±
Inner Phalangeal cells + –
Border cells + –
Outer pillar cells + ±
Inner pillar cells + ±
Inner sulcus cells + –
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4.3. Future considerations
Despite the data regarding unique expression pattern of EYA4 in the
primate, the role of EYA4 remains to be elucidated. EYA4, a member of
the Eya family, is a transcriptional coactivator that has a phosphatase
activity, which can only be active when the protein binds to SIX family
genes. We here conﬁrmed the co-expression of EYA4 with SIX1 in the
neurosensory cells, suggesting that EYA4 is activated in this region and
inﬂuences the development and maintenance of those cells. Notably, in
the marmoset cochlea, the co-expression was seen in all type of the
supporting cells while in mice the expression of EYA4 in the supporting
cell was diminished after birth. Further studies using these cell types in
primates will provide further insights into the physiological role of
EYA4 in the cochlea, which may help understand the pathophysiolo-
gical mechanisms of DFNA10 in patients. Furthermore, genetically-
modiﬁed monkeys such as transgenic/knock-out marmosets, where the
expression of EYA4 in the cochlea is speciﬁcally altered, may provide
valuable insights into the pathophysiology of EYA4-related genetic
deafness in the absence of the middle ear phenotypes, which are typi-
cally observed in Eya4-deﬁcient mouse models.
5. Conclusions
Our results revealed that EYA4 expression in the marmoset cochlea
was diﬀerent from that in the rodent cochlea. The diﬀerence in the
expression patterns may be responsible for the discrepancy observed
between the human patients and mouse models. Primate models may
provide more solid cues about the unknown pathology of EYA4-deaf-
ness.
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